DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Pavord ID, Korn S, Howarth P. , et al.
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Lancet 2012;
380 (9842): 651-659
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.